kabutan

Cyfuse Biomedical, Jan-Sep (Cumulative 3Q) Net Income Loss Narrows, Jul-Sep Net Income Loss Widens

Fri Nov 14, 2025 3:30 pm JST Earnings

4892 Cyfuse Biomedical K.K. 【J-GAAP】

Earnings Report

Cyfuse Biomedical K.K. <4892> [TSE Growth] announced its financial results after the market closed on November 14th (15:30). The net loss (non-consolidated) for the cumulative third quarter of the fiscal year ending December 2025 (January to September) was a reduced loss of 637 million yen (compared to a loss of 664 million yen in the same period last year).

Based on the cumulative third-quarter performance announced by the company and the unchanged full-year plan, our calculation indicates that the net loss for the October to December period (4Q) is expected to expand to a loss of 505 million yen (compared to a loss of 208 million yen in the same period last year).

In the most recent three-month period, from July to September (3Q), the net loss expanded to a loss of 235 million yen (compared to a loss of 217 million yen in the same period last year). However, the operating profit/loss margin improved from -2825.0% in the same period last year to -681.3%.

Kabutan News

Actual Results

Accumulated Results 3rd Quarter
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Progress Rate vs. First Half Announce Accounting Standards
Jan - Sep, 2023 29 -528 -532 -534 -68.5 ー Nov 14, 2023 J-GAAP
Jan - Sep, 2024 26 -674 -662 -664 -82.8 ー Nov 14, 2024 J-GAAP
Jan - Sep, 2025 61 -689 -635 -637 -74.7 ー Nov 14, 2025 J-GAAP
YoY +134.6% -2.2% +4.1% +4.1% +9.8%

Current Period Guidance

Second Half Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Jul - Dec, 2024 36 -448 -424 -425 -52.8 0 Feb 14, 2025 J-GAAP
Jul - Dec, 2025 Guidance 273 -748 -739 -740 -77.1 0 Aug 14, 2025 J-GAAP
YoY +658.3% -67.0% -74.3% -74.1% -45.9%

Current Period Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Dec, 2023 61 -697 -586 -589 -75.4 0 Feb 14, 2024 J-GAAP
Dec, 2024 54 -896 -869 -872 -108.3 0 Feb 14, 2025 J-GAAP
Dec, 2025 Guidance 302 -1,219 -1,140 -1,142 -118.9 0 Feb 14, 2025 J-GAAP
YoY +459.3% -36.0% -31.2% -31.0% -9.7%

Quarterly Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Operating Profit Margin Announce Accounting Standards
Jul - Sep, 2024 8 -226 -217 -217 -27.1 -2,825.0 Nov 14, 2024 J-GAAP
Oct - Dec, 2024 28 -222 -207 -208 -25.8 -792.9 Feb 14, 2025 J-GAAP
Jan - Mar, 2025 24 -240 -162 -162 -19.9 -1,000.0 May 15, 2025 J-GAAP
Apr - Jun, 2025 5 -231 -239 -240 -29.2 -4,620.0 Aug 14, 2025 J-GAAP
Jul - Sep, 2025 32 -218 -234 -235 -27.6 -681.3 Nov 14, 2025 J-GAAP
YoY +300.0% +3.5% -7.8% -8.3% -1.8%

Related Articles